Fresenius reported €1.38B in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Akzo Nobel AKZA:NA € 253M 64M
Alcon AG ALC:SW 552.89M 13.11M
AstraZeneca AZN:LN 292568.43M 24571.33M
BASF BAS:GR € 3377M 234M
Bayer BAYN:GR € 4762M 490M
Davita Healthcare Partners DVA:US $ 594.75M 90.54M
E.ON EOAN:GR 2.15B 805M
Essilor EI:FP 3.54B 1.4B
Fresenius FRE:GR € 1381M 115M
Fresenius Medical Care FME:GR € 744M 108.14M
Getinge GETIB:SS SK 1350M 115M
Givaudan GIVN:VX 810M 129M
GlaxoSmithKline GSK:LN 244700M 1400M
GN Store Nord GN:DC DK 837M 344M
Hikma Pharmaceutical HIK:LN 349M 19M
Lonza Group LONN:SW 956M 167M
Merck MRK:GR € 1791M 161M
Novartis NOVN:VX SF 4660M 108M
Philips PHIA:NA € 476M 122M
RWE RWE:GR € -611M 5134M